ArticleOncoimmunology

Results of a phase I-II study of adjuvant concurrent carboplatin and accelerated radiotherapy for triple negative breast cancer.

Silvia C Formenti et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.